Handelsbanken Fonder Ab Bio Rad Laboratories, Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 5,272 shares of BIO stock, worth $1.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,272

Previous 4,372 20.59%

Holding current value

$1.8 Million

Previous $1.19 Million 47.74%

% of portfolio

0.01%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$263.97 - $344.64 $237,573 - $310,176	900 Added 20.59%	5,272 $1.76 Million
Q2 2023 Aug 02, 2023	SELL	$359.49 - $486.4 $71,898 - $97,280	-200 Reduced 4.37%	4,372 $1.66 Million
Q1 2023 Apr 28, 2023	BUY	$418.69 - $503.0 $628,035 - $754,500	1,500 Added 48.83%	4,572 $2.19 Million
Q2 2022 Aug 03, 2022	SELL	$463.67 - $597.16 $185,468 - $238,864	-400 Reduced 11.52%	3,072 $1.52 Million
Q4 2021 Feb 08, 2022	SELL	$708.84 - $794.68 $283,536 - $317,872	-400 Reduced 10.33%	3,472 $2.62 Million
Q3 2021 Nov 10, 2021	BUY	$657.71 - $825.77 $263,084 - $330,308	400 Added 11.52%	3,872 $2.89 Million
Q2 2021 Aug 03, 2021	SELL	$576.64 - $649.04 $172,992 - $194,712	-300 Reduced 7.95%	3,472 $2.24 Million
Q4 2020 Feb 11, 2021	BUY	$510.68 - $643.45 $255,340 - $321,725	500 Added 15.28%	3,772 $2.2 Million
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $90,886 - $107,120	200 Added 6.51%	3,272 $1.69 Million
Q2 2020 Aug 13, 2020	BUY	$334.87 - $493.06 $1.03 Million - $1.51 Million	3,072 New	3,072 $1.39 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Bio Rad Laboratories, Inc. Transaction History